The global chronic inflammatory demyelinating polyneuropathy/ CIDP treatment market is experiencing/projected to experience/forecasting significant growth/expansion/development in the coming years. This trend/phenomenon/situation can be attributed to/explained by/ascribed to several factors, including a rising/increasing/growing prevalence/incidenc